Japanese biotech drug aims to reverse tooth loss by regrowing teeth. Here's how TRG-035 works, where trials stand and when it could arrive.
Activating a set of sleeping buds everyone has in their jaw could put an end to tooth loss in less than 5 years, says new ...
A drug targeting the USAG-1 protein entered human trials in Japan in 2024. Researchers aim to make third tooth regrowth available by 2030. The post New Medicine May Help Humans Grow a Third Set of ...
EN001, a novel therapy under development by ENCell, has been granted Orphan Drug Designation by the U.S. FDA for the treatment of Charcot-Marie-Tooth (CMT) disease. Phase 1 clinical trial confirmed ...